Skip to content
Pain & Fever — NaV1.8 sodium channel blockers

Suzetrigine

Prescription only

First new kind of non-opioid painkiller in decades.

Starts working
Varies
Half-life
—
In use since
2025
Pregnancy
Use with caution

Overview

Suzetrigine is a non-opioid tablet for short-term moderate to severe pain, approved in the US in January 2025. It blocks a sodium channel found almost only on pain-sensing nerves, so it doesn't cause the euphoria, breathing problems or addiction of opioids.

Conditions it's used for

How it works

Stops pain nerves outside the brain from firing, without affecting the brain itself.

Suzetrigine belongs to the NaV1.8 sodium channel blockers. How NaV1.8 sodium channel blockers work: block a sodium channel found almost only on pain-sensing nerves outside the brain, stopping pain signals at the source without the reward or breathing effects of opioids.

Uses

  • Moderate to severe acute pain in adults (e.g. after surgery)

Available as: tablet.

Typical dose

Adults
100 mg first dose on an empty stomach, then 50 mg every 12 hours, for up to 14 days.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Itching
  • Muscle spasms
  • Rash
  • Raised creatine kinase on blood tests

Serious — get medical help

Uncommon, but need prompt attention

  • Severe reactions are uncommon; long-term safety is still being studied

Warnings

  • Avoid grapefruit
  • Not with strong CYP3A4 inhibitors
  • May reduce the effect of hormonal contraceptives — use extra protection

Interactions

  • Clarithromycin, itraconazole, ritonavir — contraindicated
  • Rifampicin, carbamazepine — reduce its effect
  • Hormonal contraceptives — less effective

Other medicines in the atlas that need care with Suzetrigine, grouped by the reason:

Dangerous rise in drug levelsMajorWith Clarithromycin, Darunavir, Erythromycin, Itraconazole, Lopinavir-ritonavir and 2 more

A strong CYP3A4 inhibitor blocks breakdown of a drug where higher levels are hazardous (e.g. simvastatin — muscle breakdown; colchicine — fatal toxicity; tacrolimus — kidney damage; fentanyl or midazolam — breathing suppression).

What's usually done: Usually contraindicated or needs a planned pause or major dose change. Always check with a pharmacist.

Reduced effectModerateWith Carbamazepine, Efavirenz, Enzalutamide, Griseofulvin, Modafinil and 5 more

Enzyme induction lowers levels of this medicine, which may stop it working.

What's usually done: Monitor effect; dose changes or alternatives may be needed. The effect lasts weeks after stopping the inducer.

Check Suzetrigine against your own medicines

Pregnancy and breastfeeding

Use with caution

Too little data; use only if benefits outweigh unknown risks.

Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.

Brand names

United States
Journavx

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

History

  1. 2025

    US FDA approves Journavx (Vertex) on 30 January — the first new class of acute pain medicine in over 20 years.

The NaV1.8 target was found by studying the biology of people born unable to feel pain or with extreme pain disorders.

In trials after bunion and tummy-tuck surgery it beat placebo but was not clearly better than hydrocodone with paracetamol.

Common questions

Is it addictive?

It doesn't act on reward pathways in the brain and showed no signs of misuse potential in studies, so it is not a controlled drug.

Do I need a prescription for Suzetrigine?

Yes — Suzetrigine is prescription-only in most countries.

Can I take Suzetrigine during pregnancy?

Use with caution. Too little data; use only if benefits outweigh unknown risks. Always check with a doctor or midwife.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.